{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:11:30Z","timestamp":1750219890341,"version":"3.41.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":127,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100513","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:19:21Z","timestamp":1746811161000},"page":"100513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding RNAs: Emerging contributors to chemoresistance in chronic myeloid leukemia"],"prefix":"10.1016","volume":"23","author":[{"given":"Laya","family":"Ghadyani nejhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-2578","authenticated-orcid":false,"given":"Mahsa","family":"Sohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin Alizad","family":"Ghandforoush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrbano","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9976","key":"10.1016\/j.lrr.2025.100513_bib0001","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"The Lancet"},{"issue":"9584","key":"10.1016\/j.lrr.2025.100513_bib0002","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.lrr.2025.100513_bib0003","series-title":"Chronic myeloid leukaemia","first-page":"603","author":"Goldman","year":"2005"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0004","first-page":"106","article-title":"Bilateral maxillary, sphenoid sinuses and lumbosacral spinal cord extramedullary relapse of CML following allogeneic stem cell transplant","volume":"10","author":"Hosseini","year":"2016","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0005","unstructured":"Negrin, R.S. and C.A. Schiffer, Overview of the treatment of chronic myeloid leukemia. 2017, UpToDate."},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","article-title":"Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia","volume":"32","author":"Dusetzina","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0007","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?","volume":"14","author":"Rosti","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12920-016-0194-5","article-title":"Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia","volume":"9","author":"Cha","year":"2016","journal-title":"BMC. Med. Genomics."},{"issue":"20","key":"10.1016\/j.lrr.2025.100513_bib0010","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","article-title":"Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis","volume":"26","author":"De Lavallade","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lrr.2025.100513_bib0011","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome\u2013positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100513_bib0012","first-page":"461","volume":"2009","author":"Bixby","year":"2009"},{"key":"10.1016\/j.lrr.2025.100513_bib0013","series-title":"Resistance to Tyrosine Kinase Inhibitors","first-page":"109","article-title":"The resistance to tyrosine kinase inhibitors in chronic myeloid leukemia: an overview","author":"Galimberti","year":"2016"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0014","first-page":"107","article-title":"Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?","volume":"39","author":"Yap","year":"2017","journal-title":"Malays. J. Pathol."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hoc.2011.09.004","article-title":"Chronic myeloid leukemia \u2013 Mechanisms of resistance and treatment","volume":"25","author":"Jabbour","year":"2011","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.lrr.2025.100513_bib0016","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3906\/biy-1405-21","article-title":"Multidrug resistance in chronic myeloid leukemia","volume":"38","author":"\u00dcnl\u00fc","year":"2014","journal-title":"Turkish J. Biol. (Basel)"},{"issue":"24","key":"10.1016\/j.lrr.2025.100513_bib0017","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia","volume":"15","author":"Milojkovic","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0018","article-title":"The interface between BCR-ABL-dependent and-independent resistance signaling pathways in chronic myeloid leukemia","volume":"2012","author":"Nestal de Moraes","year":"2012","journal-title":"Leuk. Res. Treatment."},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cancers9040038","article-title":"Long non-coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells","volume":"9","author":"Heery","year":"2017","journal-title":"Cancers. (Basel)"},{"issue":"26","key":"10.1016\/j.lrr.2025.100513_bib0020","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867321666140414101939","article-title":"Mechanism of cancer drug resistance and the involvement of noncoding RNAs","volume":"21","author":"Xia","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"15","key":"10.1016\/j.lrr.2025.100513_bib0021","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.febslet.2015.04.061","article-title":"Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia","volume":"589","author":"Xing","year":"2015","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0022","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3892\/ol.2016.4738","article-title":"Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia","volume":"12","author":"Gao","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-015-0465-3","article-title":"MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45\u03b1","volume":"14","author":"Yang","year":"2015","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0024","first-page":"1704","article-title":"LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p","volume":"7","author":"He","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4062\/biomolther.2016.162","article-title":"LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21","volume":"25","author":"Zhou","year":"2017","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0026","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/embor.2009.181","article-title":"Pervasive transcription constitutes a new level of eukaryotic genome regulation","volume":"10","author":"Berretta","year":"2009","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.lrr.2025.100513_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003569","article-title":"Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs","volume":"9","author":"Hangauer","year":"2013","journal-title":"PLoS Genet."},{"issue":"7414","key":"10.1016\/j.lrr.2025.100513_bib0028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0029","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1534\/genetics.112.146704","article-title":"Long noncoding RNAs: past, present, and future","volume":"193","author":"Kung","year":"2013","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg3606","article-title":"Long non-coding RNAs: new players in cell differentiation and development","volume":"15","author":"Fatica","year":"2014","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","article-title":"Roles, functions, and mechanisms of long non-coding RNAs in cancer","volume":"14","author":"Fang","year":"2016","journal-title":"Genomics. Proteomics. Bioinformatics."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-017-9712-y","article-title":"MicroRNAs and metastasis: small RNAs play big roles","volume":"37","author":"Kim","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lrr.2025.100513_bib0033","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.biopha.2018.07.133","article-title":"Epigenetics and epi-miRNAs: potential markers\/therapeutics in leukemia","volume":"106","author":"Memari","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0034","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41598-018-20232-4","article-title":"Lnc2Catlas: an atlas of long noncoding RNAs associated with risk of cancers","volume":"8","author":"Ren","year":"2018","journal-title":"Sci. Rep."},{"issue":"69","key":"10.1016\/j.lrr.2025.100513_bib0035","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21922","article-title":"LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3\/GDH axis","volume":"8","author":"Zeng","year":"2017","journal-title":"Oncotarget."},{"issue":"41","key":"10.1016\/j.lrr.2025.100513_bib0036","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/onc.2017.184","article-title":"LncRNA-mediated regulation of cell signaling in cancer","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0037","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-017-0680-1","article-title":"STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-018-0783-3","article-title":"Linc00210 drives wnt\/\u03b2-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner","volume":"17","author":"Fu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0039","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdx248","article-title":"CCAT1 and CCAT2 long noncoding RNAs, located within the 8q. 24.21 \u2018gene desert\u2019, serve as important prognostic biomarkers in colorectal cancer","volume":"28","author":"Ozawa","year":"2017","journal-title":"Ann. Oncol."},{"year":"2017","series-title":"Oncogenic Function and Molecular Mechanism of H19 Noncoding RNA in Colorectal Cancer","author":"Ling","key":"10.1016\/j.lrr.2025.100513_bib0040"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0041","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5114\/amscd.2017.71413","article-title":"Identification of differentially expressed profiles of lncRNAs and mRNAs in ER-negative and HER-2 positive breast cancer","volume":"2","author":"Qian","year":"2017","journal-title":"Arch. Med. Sci.-Civiliz. Dis."},{"issue":"46","key":"10.1016\/j.lrr.2025.100513_bib0042","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/onc.2017.246","article-title":"Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer","volume":"36","author":"Heilmann","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.lrr.2025.100513_bib0043","first-page":"1","article-title":"An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme","author":"Zhou","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"51","key":"10.1016\/j.lrr.2025.100513_bib0044","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25434","article-title":"Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma","volume":"9","author":"Paul","year":"2018","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0045","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.18632\/oncotarget.13936","article-title":"A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration","volume":"8","author":"Ouimet","year":"2017","journal-title":"Oncotarget."},{"issue":"16","key":"10.1016\/j.lrr.2025.100513_bib0046","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24401","article-title":"Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells","volume":"9","author":"Garitano-Trojaola","year":"2018","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0047","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MOH.0000000000000354","article-title":"Long non-coding RNAs in leukemia: biology and clinical impact","volume":"24","author":"Lammens","year":"2017","journal-title":"Curr. Opin. Hematol."},{"year":"2017","series-title":"OP0157 Apoptosis Resistance of Synovial Fibroblasts of Patients with Rheumatoid Arthritis is Regulated by the Long Non-Coding RNA FAS-AS1","author":"Pajak","key":"10.1016\/j.lrr.2025.100513_bib0048"},{"key":"10.1016\/j.lrr.2025.100513_bib0049","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2016.12.005","article-title":"LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2","volume":"388","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lrr.2025.100513_bib0050","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-4379","article-title":"Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression","author":"Aguilo","year":"2011","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0051","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1349-7006.2006.00305.x","article-title":"Expression profile of LIT1\/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers","volume":"97","author":"Nakano","year":"2006","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.lrr.2025.100513_bib0052","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"129","author":"Rinn","year":"2007","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.lrr.2025.100513_bib0053","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gkq285","article-title":"CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nature Rev. Genet."},{"issue":"14","key":"10.1016\/j.lrr.2025.100513_bib0055","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1093\/nar\/gks296","article-title":"Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs","volume":"40","author":"Moran","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0056","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molcel.2008.08.022","article-title":"Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation","volume":"32","author":"Pandey","year":"2008","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003368","article-title":"Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB","volume":"9","author":"Tripathi","year":"2013","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0058","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","article-title":"The imprinted H19 lncRNA antagonizes let-7 microRNAs","volume":"52","author":"Kallen","year":"2013","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0059","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13059-015-0705-2","article-title":"Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis","volume":"16","author":"Fan","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.lrr.2025.100513_bib0060","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-16-0356","article-title":"LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1 and DNMT1","author":"Sun","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0061","first-page":"0921","article-title":"A novel lncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern","author":"Sun","year":"2016","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0062","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.devcel.2012.12.012","article-title":"The tissue-specific lncRNA fendrr is an essential regulator of heart and body wall development in the mouse","volume":"24","author":"Grote","year":"2013","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0063","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0064","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018622","article-title":"Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers","volume":"7","author":"Kim","year":"2015","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"key":"10.1016\/j.lrr.2025.100513_bib0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03523","article-title":"Long non-coding RNAs as a source of new peptides","volume":"3","author":"Ruiz-Orera","year":"2014","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0066","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.celrep.2014.07.045","article-title":"Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes","volume":"8","author":"Ingolia","year":"2014","journal-title":"Cell Rep."},{"issue":"7146","key":"10.1016\/j.lrr.2025.100513_bib0067","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nature05874","article-title":"Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project","volume":"447","author":"Consortium","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0068","doi-asserted-by":"crossref","first-page":"e1559","DOI":"10.1371\/journal.pone.0001559","article-title":"Predicted functional RNAs within coding regions constrain evolutionary rates of yeast proteins","volume":"3","author":"Warden","year":"2008","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0069","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"issue":"5725","key":"10.1016\/j.lrr.2025.100513_bib0070","first-page":"1149","article-title":"Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution","volume":"308","author":"Cheng","year":"2005","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0071","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1440-169X.2011.01303.x","article-title":"Long non-coding RNAs in nuclear bodies","volume":"54","author":"Ip","year":"2012","journal-title":"Dev. Growth Differ."},{"issue":"5740","key":"10.1016\/j.lrr.2025.100513_bib0072","first-page":"1559","article-title":"The transcriptional landscape of the mammalian genome","volume":"309","author":"Carninci","year":"2005","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0073","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/gr.4200206","article-title":"Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome","volume":"16","author":"Ravasi","year":"2006","journal-title":"Genome Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0074","series-title":"Nuclear Bodies and Noncoding RNAs","first-page":"321","article-title":"Knockdown of nuclear-retained long noncoding RNAs using modified DNA antisense oligonucleotides","author":"Zong","year":"2015"},{"issue":"7006","key":"10.1016\/j.lrr.2025.100513_bib0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lrr.2025.100513_bib0076","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-genet-120213-092023","article-title":"A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome","volume":"49","author":"Fromm","year":"2015","journal-title":"Annu. Rev. Genet."},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0077","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol. (Basel)"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0078","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0079","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"issue":"7044","key":"10.1016\/j.lrr.2025.100513_bib0080","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nature03816","article-title":"Stem cell division is regulated by the microRNA pathway","volume":"435","author":"Hatfield","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0081","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2006.05.009","article-title":"MicroRNAs: a new class of regulatory genes affecting metabolism","volume":"4","author":"Kr\u00fctzfeldt","year":"2006","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.lrr.2025.100513_bib0082","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","article-title":"miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0083","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/14737159.7.5.569","article-title":"Role of miRNA in carcinogenesis and biomarker selection: a methodological view","volume":"7","author":"Ahmed","year":"2007","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0084","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.lrr.2025.100513_bib0085","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","article-title":"MicroRNA-cancer connection: the beginning of a new tale","volume":"66","author":"Calin","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0086","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1590\/S0100-879X2007001100003","article-title":"miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia","volume":"40","author":"Zanette","year":"2007","journal-title":"Brazil. J. Med. Biol. Res."},{"issue":"24","key":"10.1016\/j.lrr.2025.100513_bib0087","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0088","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1476-4598-10-108","article-title":"Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0089","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Pol\u00e1kov\u00e1","year":"2011","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0091","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0092","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2007-09-113175","article-title":"Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I","volume":"111","author":"Gontarewicz","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0093","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0094","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2404897","article-title":"Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2","volume":"22","author":"Shukla","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12185-012-1235-2","article-title":"Genetic and epigenetic alterations of myeloproliferative disorders","volume":"97","author":"Milosevic","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"5538","key":"10.1016\/j.lrr.2025.100513_bib0096","first-page":"2163","article-title":"Roots of clinical resistance to STI-571 cancer therapy","volume":"293","author":"Barthe","year":"2001","journal-title":"Science (1979)"},{"issue":"6","key":"10.1016\/j.lrr.2025.100513_bib0097","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1179\/1607845413Y.0000000095","article-title":"Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib","volume":"18","author":"Chahardouli","year":"2013","journal-title":"Hematology."},{"issue":"6","key":"10.1016\/j.lrr.2025.100513_bib0098","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jcpt.12197","article-title":"Clinical impact of ABCC 1 and ABCC 2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients","volume":"39","author":"Au","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0099","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4143\/crt.2014.012","article-title":"Genetic variations of drug transporters can influence on drug response in patients treated with docetaxel chemotherapy","volume":"47","author":"Choi","year":"2015","journal-title":"Cancer Res. Treatment: Official J. Korean Cancer Assoc."},{"issue":"6","key":"10.1016\/j.lrr.2025.100513_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bdd.764","article-title":"MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines","volume":"32","author":"Rodrigues","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0101","first-page":"1127","article-title":"MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2","volume":"9","author":"Tian","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"10.1016\/j.lrr.2025.100513_bib0102","first-page":"955","article-title":"Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL","volume":"68","author":"Zhan","year":"2013","journal-title":"Die Pharmazie- Int. J. Pharmaceut. Sci."},{"issue":"12","key":"10.1016\/j.lrr.2025.100513_bib0103","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100513_bib0104","article-title":"Drug transporters and imatinib treatment: implications for clinical practice","author":"Eechoute","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10245332.2016.1258152","article-title":"The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells","volume":"22","author":"Wang","year":"2017","journal-title":"Hematology."},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0106","first-page":"3342","article-title":"Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0107","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1039\/C7RA12520H","article-title":"SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155","volume":"8","author":"Yan","year":"2018","journal-title":"RSC. Adv."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/exd.12868","article-title":"Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma","volume":"25","author":"Ichigozaki","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.lrr.2025.100513_bib0109","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13875","article-title":"SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization","volume":"7","author":"Damas","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1096\/fj.201600994R","article-title":"The lncRNA SNHG5\/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4","volume":"31","author":"Zhao","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.lrr.2025.100513_bib0111","article-title":"The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targeting miR-377\/CASP1 axis","author":"Wang","year":"2018","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0112","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3892\/or.2017.5828","article-title":"MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lrr.2025.100513_bib0113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","article-title":"The long noncoding RNA MEG3 and its target miR-147 regulate JAK\/STAT pathway in advanced chronic myeloid leukemia","volume":"34","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0114","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1007\/s13277-016-4917-1","article-title":"UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis","volume":"37","author":"Yang","year":"2016","journal-title":"Tumor Biol. (Basel)"},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jjco\/hyv132","article-title":"Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer","volume":"45","author":"Li","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0116","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1038\/cddis.2013.541","article-title":"Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)","volume":"5","author":"Huang","year":"2015","journal-title":"Cell Death. Dis."},{"issue":"7","key":"10.1016\/j.lrr.2025.100513_bib0117","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/febs.12737","article-title":"Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating wnt signaling","volume":"281","author":"Fan","year":"2014","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/dna.2016.3533","article-title":"lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells","volume":"36","author":"Xiao","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.lrr.2025.100513_bib0119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gene.2017.01.004","article-title":"Long noncoding RNA HULC promotes cell proliferation by regulating PI3K\/AKT signaling pathway in chronic myeloid leukemia","volume":"607","author":"Lu","year":"2017","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-018-0884-z","article-title":"The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lrr.2025.100513_bib0121","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211052150","article-title":"LncRNA OIP5-AS1 promotes the autophagy-related imatinib resistance in chronic myeloid leukemia cells by regulating miR-30e-5p\/ATG12 axis","volume":"20","author":"Dai","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0122","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.lrr.2025.100513_bib0123","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41419-020-03083-8","article-title":"Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5\/ATG12-mediated autophagy via miR-372-3p","volume":"11","author":"He","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41419-020-2268-8","article-title":"Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93\/ATG12 axis in colorectal cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","article-title":"Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer","volume":"16","author":"YiRen","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1\u20134","key":"10.1016\/j.lrr.2025.100513_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2018.09.034","article-title":"LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia","volume":"507","author":"Wen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lrr.2025.100513_bib0127","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2018.02.130","article-title":"LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation","volume":"101","author":"Fang","year":"2018","journal-title":"Biomed. PharmacOther"},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196603","article-title":"Loss of Malat1 does not modify age- or diet-induced adipose tissue accretion and insulin resistance in mice","volume":"13","author":"Carter","year":"2018","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0129","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3892\/or.2017.5468","article-title":"Absence of Malat1 does not prevent DEN-induced hepatocarcinoma in mice","volume":"37","author":"Miard","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.14882","article-title":"Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma","volume":"179","author":"Handa","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0131","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.21037\/apm-20-343","article-title":"Systematic analysis reveals a lncRNA-miRNA-mRNA network associated with dasatinib resistance in chronic myeloid leukemia","volume":"10","author":"Luo","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.lrr.2025.100513_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643043","article-title":"The tyrosine kinase-driven networks of novel long non-coding RNAs and their molecular targets in myeloproliferative neoplasms","volume":"9","author":"Wong","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.lrr.2025.100513_bib0133","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.21037\/tcr-24-281","article-title":"LncRNA CBR3-AS1 is associated with the BCR::ABL1 kinase independent mechanism of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia patients","volume":"13","author":"Lin","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0134","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171383","article-title":"Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2","volume":"38","author":"Deng","year":"2018","journal-title":"Biosci. Rep."},{"issue":"10","key":"10.1016\/j.lrr.2025.100513_bib0135","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","article-title":"Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL\u2013positive cells","volume":"15","author":"Kominsky","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0136","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-12-0001","article-title":"microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis and angiogenesis of neuroblastoma cells","author":"Zhang","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lrr.2025.100513_bib0137","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.335943","article-title":"MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells","author":"Selcuklu","year":"2012","journal-title":"J. Biol. Chem. (Easton)"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0138","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12032-011-9975-z","article-title":"MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility","volume":"29","author":"Zhu","year":"2012","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0139","doi-asserted-by":"crossref","first-page":"e2830","DOI":"10.1038\/cddis.2017.223","article-title":"Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML","volume":"8","author":"Zhao","year":"2017","journal-title":"Cell Death. Dis."},{"issue":"22","key":"10.1016\/j.lrr.2025.100513_bib0140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/jnci\/djt302","article-title":"miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition","volume":"105","author":"Sun","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.lrr.2025.100513_bib0141","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1007\/s13277-015-3713-7","article-title":"miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer","volume":"36","author":"Wang","year":"2015","journal-title":"Tumor Biol. (Basel)"},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0142","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12860-019-0194-3","article-title":"MicroRNA suppression of stress-responsive NDRG2 during dexamethasone treatment in skeletal muscle cells","volume":"20","author":"Mir","year":"2019","journal-title":"BMC. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100513_bib0143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-014-0568-y","article-title":"Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients","volume":"16","author":"Lim","year":"2015","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0144","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.yexcr.2013.02.002","article-title":"miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR\/ABL1 protein","volume":"319","author":"Li","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.leukres.2012.12.003","article-title":"Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia","volume":"37","author":"Liu","year":"2013","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0146","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2015.02.031","article-title":"Restoration of miR-424 suppresses BCR\u2013ABL activity and sensitizes CML cells to imatinib treatment","volume":"360","author":"Hershkovitz-Rokah","year":"2015","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0147","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/leu.2012.65","article-title":"Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells","volume":"26","author":"Yu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2025.100513_bib0148","doi-asserted-by":"crossref","DOI":"10.1038\/srep12460","article-title":"MicroRNA-320a acts as a tumor suppressor by targeting BCR\/ABL oncogene in chronic myeloid leukemia","volume":"5","author":"Xishan","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.lrr.2025.100513_bib0149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068442","article-title":"Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/cgt.2014.44","article-title":"The malignancy suppression role of miR-23a by targeting the BCR\/ABL oncogene in chromic myeloid leukemia","volume":"21","author":"Xishan","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lrr.2025.100513_bib0151","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.HS9.0000844540.71364.57","article-title":"P413: thepotential use of an oral hypomethylating agent, or-2100, AS a combination therapy for myeloid malignancies","volume":"6","author":"Kamachi","year":"2022","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0152","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","article-title":"ADAR1 Activation drives leukemia stem cell self-renewal by impairing let-7 biogenesis","volume":"19","author":"Zipeto","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lrr.2025.100513_bib0153","article-title":"miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lrr.2025.100513_bib0154","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.lrr.2025.100513_bib0155","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17706","article-title":"Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells","volume":"8","author":"Salati","year":"2017","journal-title":"Oncotarget."},{"issue":"10","key":"10.1016\/j.lrr.2025.100513_bib0156","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2015.07.008","article-title":"Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway","volume":"39","author":"Wang","year":"2015","journal-title":"Leuk. Res."},{"issue":"9","key":"10.1016\/j.lrr.2025.100513_bib0157","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood.2020006881","article-title":"Human TET2 bridges cancer and immunity","volume":"136","author":"Zhang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100513_bib0158","article-title":"MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells","volume":"112","author":"Ma","year":"2019","journal-title":"Biomed. (Taipei) Pharmacother."},{"issue":"4","key":"10.1016\/j.lrr.2025.100513_bib0159","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm.4499","article-title":"Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.lrr.2025.100513_bib0160","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cell.2010.01.007","article-title":"miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts","volume":"140","author":"Eiring","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lrr.2025.100513_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110038","article-title":"AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p","volume":"84","author":"Pan","year":"2021","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.lrr.2025.100513_bib0162","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1080\/10428194.2018.1543875","article-title":"MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5","volume":"60","author":"Jiang","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.lrr.2025.100513_bib0163","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.4161\/cc.28758","article-title":"miR-221\/222 control luminal breast cancer tumor progression by regulating different targets","volume":"13","author":"Dentelli","year":"2014","journal-title":"Cell Cycle"},{"issue":"26","key":"10.1016\/j.lrr.2025.100513_bib0164","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11480","article-title":"Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses","volume":"8","author":"Bourgeais","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.lrr.2025.100513_bib0165","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1158\/0008-5472.CAN-13-0940","article-title":"Contribution of bcl-2 phosphorylation to bak binding and drug resistance","volume":"73","author":"Dai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lrr.2025.100513_bib0166","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbi.2018.06.006","article-title":"microRNA-199a\/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells","volume":"291","author":"Chen","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"16","key":"10.1016\/j.lrr.2025.100513_bib0167","first-page":"7008","article-title":"MicroRNA-577 promotes the sensitivity of chronic myeloid leukemia cells to imatinib by targeting NUP160","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.lrr.2025.100513_bib0168","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41419-021-04209-2","article-title":"Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.lrr.2025.100513_bib0169","first-page":"1693","article-title":"Decreased expression of microRNA-214 contributes to imatinib mesylate resistance of chronic myeloid leukemia patients by upregulating ABCB1 gene expression","volume":"16","author":"Jin","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"1\u20132","key":"10.1016\/j.lrr.2025.100513_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2014.02.008","article-title":"ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance","volume":"53","author":"Ferreira","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.lrr.2025.100513_bib0171","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.gene.2017.05.030","article-title":"Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression","volume":"626","author":"Zhou","year":"2017","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.lrr.2025.100513_bib0172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115003","article-title":"Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line","volume":"9","author":"Bhutra","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.lrr.2025.100513_bib0173","article-title":"Downregulation of Mir-181a restores chemosensitivity to imatinib mesylate in chronic myeloid leukemia cells resistant to tyrosine kinase inhibitors","author":"Chorzalska","year":"2015","journal-title":"Am. Soc. Hematol."},{"issue":"37","key":"10.1016\/j.lrr.2025.100513_bib0174","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11054","article-title":"Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget."},{"issue":"54","key":"10.1016\/j.lrr.2025.100513_bib0175","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21272","article-title":"MicroRNA-212\/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells","volume":"8","author":"Kaehler","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.lrr.2025.100513_bib0176","article-title":"Expression profiling of micro RNAs (MiRNAs) and long non-coding RNAs (lncRNAs) in chronic myeloid leukemia (CML) patients in the State of Qatar","author":"Al-Dewik","year":"2017","journal-title":"Am Soc Hematology"},{"issue":"2","key":"10.1016\/j.lrr.2025.100513_bib0177","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.18632\/oncotarget.23274","article-title":"Dihydroartemisinin-regulated mRNAs and lncRNAs in chronic myeloid leukemia","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:15:57Z","timestamp":1750180557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":177,"alternative-id":["S2213048925000159"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100513","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs: Emerging contributors to chemoresistance in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100513"}}